Showing results (71-80 of 447) with videos related to
Sort By:
Pageof 45
Heart Rhythm|October 31, 2012
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic reviewAndrew H Ha, Inje Ham, Girish M Nair, et al.Critical Care (London, England)|June 16, 2022
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysisOlivia S Costa, Stuart J Connolly, Mukul Sharma, et al.American Heart Journal|August 30, 2003
Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trialsStuart J Connolly, Daniel J Schnell, Richard L Page, et al.Plos One|January 16, 2020
Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-studyFinlay A McAlister, Rajibul Mian, Jonas Oldgren, et al.Circulation|July 5, 2006
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trialStefan H Hohnloser, Paul Dorian, Robin Roberts, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 18, 2011
Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA studyChristian Torp-Pedersen, Harry J G M Crijns, Christophe Gaudin, et al.Implementation Science : IS|August 10, 2011
Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic reviewRobby Nieuwlaat, Stuart J Connolly, Jean A Mackay, et al.Journal of the American College of Cardiology|June 18, 2013
Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillationJohn W Eikelboom, Stuart J Connolly, Robert G Hart, et al.American Heart Journal|March 30, 2002
Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-responseRichard L Page, Stuart J Connolly, William E Wilkinson, et al.Circulation. Arrhythmia and Electrophysiology|May 11, 2016
Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure TrialStephen B Wilton, Derek V Exner, D George Wyse, et al.Pageof 45